Filing Details
- Accession Number:
- 0001127602-21-009099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 16:05:16
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 16:05:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492422 | Apellis Pharmaceuticals Inc. | APLS | Pharmaceutical Preparations (2834) | 271537290 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1657874 | D Nicole Perry | C/O Apellis Pharmaceuticals, Inc. 100 Fifth Avenue, 3Rd Floor Waltham MA 02451 | Vice President - Accounting | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-01 | 2,000 | $3.76 | 4,347 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 2,000 | $50.00 | 2,347 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-01 | 2,000 | $0.00 | 2,000 | $3.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,161 | 2025-07-31 | No | 4 | M | Direct |
Footnotes
- This is a scheduled exercise from a 10B5-1 trading plan.
- This option was granted on July 31, 2015 and is fully vested.